Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-001949

CVP,Strategy/Corp Development sold 11,000 shares at an average $85.83 ($944,155)

  • CVP,Strategy/Corp Development acquired 11,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BOBO DONALD E JR · CVP,Strategy/Corp Development

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-13 Exercise or conversion : show line 1 in the form 10b5-1 +11,000 $36.75 $404,250 50,502.69 D
2024-02-13 Sale : show line 2 in the form 10b5-1 −470 $86.35 $40,582 50,032.69 D
2024-02-13 Sale : show line 3 in the form 10b5-1 −10,530 $85.81 $903,573 39,502.69 D
Open-market sales · 11,000 sh · avg $85.83 · $944,155

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-02-13 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −11,000 $36.75 2024-05-10 11,000 27,000 D
Loading xslF345X05/doc4.xml…